Compromise of immune function in obstructive jaundice

European Journal of Surgery

Volumn 168, Issue 6, 2002, Pages 315-328

  Nehéz, László ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immune function; Intervention; Obstructive jaundice

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; CELLULAR IMMUNITY; CYTOKINE RELEASE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; KUPFFER CELL; LIVER CIRCULATION; MACROPHAGE ACTIVATION; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW;

ANIMALS; ANTIBODY FORMATION; BACTERIAL TRANSLOCATION; BILE ACIDS AND SALTS; CHOLESTASIS; CYTOKINES; HEPATOCYTES; HUMANS; IMMUNITY, CELLULAR; INTESTINAL ABSORPTION; KUPFFER CELLS; LIVER CIRCULATION; MACROPHAGES; MICROCIRCULATION; NEURAL CELL ADHESION MOLECULES; NEUTROPHILS;

EID: 0036403403     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/11024150260284815     Document Type: Review

References (184)

1. Aagaard BDL, Heyworth MF, Oesterle AL, Jones AL, Way LW. Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut 1996; 39: 136-140.
2. Adachi Y, Arii S, Sasaoki T, et al. Hepatic macrophage malfunction in rats with obstructive jaundice and its biological significance. J Hepatol 1992; 16: 171-176.
3. Akiyama T, Hasegawa T, Sejima T, Sahara H, Saito H, Takashima S. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology 1998; 45: 665-671.
4. Andersson R, Tranberg KG, Lillienau J, et al. Influence of individual bile acids in Escherichia coli peritonitis. Scand J Gastroenterol 1990; 25: 1129-1136.
5. Andy OJ, Grogan JB, Griswold JA, Scott-Conner CEH. Peritoneal neutrophil chemotaxis is impaired in biliary obstruction. Am Surg 1992; 58: 28-31.
6. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989; 10: 299-304.
7. Ballieux BE, Hiemstra PS, Klar-Mohamed N, Hagen EC, van Es LA, van der Woude FJ. Detachment cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 1994; 24: 3211-3215.
8. Bauer M, Zhang JX, Bauer I. ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action. Am J Physiol 1994; 267: 143-149.
9. Baeuerle PA, Henkel T. Function and activation of NF- κB in the immune system. Annu Rev Immunol 1994; 12: 141-197.
10. Beierle EA, Vauthey JN, Moldaver LL, Copeland EM. Hepatic tumor necrosis factor-α production and distant organ dysfunction in a murine model of obstructive jaundice. Am J Surg 1996; 171: 202-206.
11. Bemelmans MHA, Buurman WA, Gouma DJ. The presence of TNF and soluble TNF receptors in obstructive jaundice. Gastroenterology 1993; 104 (Suppl.): A665.
12. Bemelmans MHA, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor (TNF) clearance in murine model. J Immunol 1993; 150: 2007-2017.
13. Bemelmans MHA, Gouma DJ, Buurman WA. LPS induced sTNFr release in vivo in murine model: Investigation of the role of TNF, IL-1, LIF and IFNγ. J Immunol 1993; 151: 5554-5562.
14. Bemelmans MHA, Gouma DJ, Buurman WA. Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 1994; 6: 609-615.
15. Bemelmans MHA, Gouma DJ, Greve JW, Buurman WA. Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br J Surg 1993; 80: 1055-1058.
16. Bemelmans MHA, Greve JWM, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice, soluble TNF receptors as prognostic factors for mortality. Gut 1996; 38: 447-453.
17. Berkow RL, Dodson MR. Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J Leukoc Biol 1988; 44: 345-352.
18. Bhathal PS, Gall JAM. Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus. Liver 1985; 5: 311-325.
19. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 1999; 276: 1137-1144.
20. Bilzer M, Lautenburg BH. Oxidant stress and potentiation of ischaemia/repefusion injury to the perfused rat liver by human polymorphonuclear leucocytes. J Hepatol 1994; 20: 473-477.
21. Binder HJ, Filburn B, Floch M. Bile acid inhibition of intestinal anaerobic organisms. Am J Clin Nutr 1975; 28: 119-125.
22. Boermeester MA, Houdijk APJ, Meyer S. Liver failure due to partial hepatectomy in rats induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability increasing protein. Am J Pathol 1995; 147: 1428-1440.
23. Brown WR, Kloppel TM. Liver and IgA: Immunological, cell biological and clinical implications. Hepatology 1989; 9: 763-784.
24. Bueno MR, Daneri A, Armendariz-Borunda J. Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity. J Hepatol 2000; 33: 915-925.
25. Cainzos M, Alcalde JA, Potel J, Puente JL. Hyperbilirubinaemia, jaundice and anergy. Hepatogastroenterology 1992; 39: 330-332.
26. Calmus Y, Gueochot J, Podevin P, Bonnefis MT, Giboudeau J. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin-1, interleukin-6 and tumor necrosis factor alpha production by monocytes. Hepatology 1992; 16: 719-723.
27. Carey PD, Jenkins JK, Byrne K, Schneider AM, Walsh CJ, Fowler AD. Neutrophil short-lived oxidant production: Enhancement following onset of sepsis induced lung injury. Circ Shock 1992; 36: 256-264.
28. Clements WDB, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 1998; 42: 293-299.
29. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol 1998; 29: 550-558.
30. Dahm LJ, Shultze AE, Roth RA. Activated neutrophils injure the isolated, perfused rat liver by an oxygen radical-dependent mechanism. Am J Pathol 1991; 139: 1009-1020.
31. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990; 159: 79-84.
32. Ding JW, Andersson R, Hultberg B, Soltesz V, Bengmark S. Modification of reticuloendothelial function by muramyl dipeptide-encapsulated liposomes in jaundiced rats treated with biliary decompression. Scand J Gastroenterol 1993; 28: 53-62.
33. Ding JW, Andersson R, Norgren L, Stenram U, Bengmark S. The influence of biliary obstruction and sepsis on reticuloendothelial function in rats. Eur J Surg 1992; 158: 157-164.
34. Ding JW, Andersson R, Soltesz V, Bengmark S. The role of bile and bile acid in bacterial translocation in obstructive jaundice in rats. Eur Surg Res 1993; 25: 11-19.
35. Ding JW, Andersson R, Soltesz VL, et al. Inhibition of bacterial translocation in obstructive jaundice by MTP-PE in the rat. J Hepatol 1994; 20: 720-728.
36. Ding JW, Andersson R, Stenram U. Effect of biliary decompression on reticuloendothelial function in jaundiced rats. Br J Surg 1992; 79: 648-652.
37. Dixon JM, Armstrong CP, Duffy SW, Davies GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice, a review of 373 patients. Gut 1983; 24: 845-852.
38. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-gamma: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
39. Edwards JCW, Sedgwick AD, Willoughby DA. The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system. J Pathol 1981; 134: 147-156.
40. Emancipator SN, Gallo GR, Raxaboni R, Lamm ME. Experimental cholestasis promotes the deposition of glomerular IgA immune complexes. Am J Pathol 1983; 113: 19-26.
41. Feldmann G. Liver apoptosis. J Hepatol 1997; 26 (suppl. 2): 1-11.
42. Fisher CJ Jr, Dhainaut JF, Opal SM, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994; 271: 1836-1843.
43. Floch MH, Binder HJ, Gershengoren W. The effect of bile acids on intestinal microflora. Am J Clin Nutr 1972; 25: 1418-1426.
44. Foley DP, Collins BR, Magee JC, et al. Bile acids in xenogeneic ex-vivo liver perfusion: Function of xeno-perfused livers and compatibility with human bile salts and porcine livers. Transplantation 2000; 69: 242-248.
45. Fox ES, Kim JC, Tracy TF. NF-κB activation and modulation in hepatic macrophages during cholestatic injury. J Surg Res 1997; 72: 129-134.
46. Fubara ES, Freter R. Protection against enteric bacterial infection by secretory IgA antibodies. J Immunol 1973; 111: 395-403.
47. Fumarulo R, Conese M, Riccardi S, et al. Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leucocytes. Agents Actions 1991; 34: 339-344.
48. Furie MB, Tancinco MC, Smith CW. Monoclonal antibodies to leucocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 1991; 78: 2089-2097.
49. Gonzalez-Correa JA, De La Cruz JP, Martin-Aurioles EM, Lopez-Egea MA, Ortiz P, De La Cuesta FS. Effects of S-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats. Hepatology 1997; 26: 121-127.
50. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 1988; 75: 216-219.
51. Greve JWM, Gouma DJ, Buurman WA. Complications in obstructive jaundice: Role of endotoxins. Scand J Gastroenterol 1992; 194: 8-12.
52. Greve JWM, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: A study with germ free rats. Gastroenterology 1990; 98: 478-485.
53. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Lactulose inhibits endotoxin-induced tumour necrosis factor production by monocytes. Gut 1990; 31: 198-203.
54. Greve JW, Maessen JG, Yiebosch T, Buurman WA, Gouma DJ. Prevention of postoperative complications in jaundiced rats. Ann Surg 1990; 212: 221-227.
55. Gross JB, Reichen J, Zeltner T, Zimmermann A. The evolution of changes in quantitative liver function tests in a rat model of cirrhosis: Correlation with morphometric measurement of hepatocyte mass. Hepatology 1987; 7: 457-463.
56. Haga Y, Sakamoto K, Egami H, et al. Changes in production of interleukin-1 and interleukin-2 associated with obstructive jaundice and biliary drainage in patients with gastrointestinal cancer. Surgery 1989; 106: 842-848.
57. Haga Y, Tempero MA, Zetterman RK. Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity of human lymphocytes. Biochym Biophys Acta 1996; 1316: 29-34.
58. Haga Y, Tempero MA, Zetterman RK. Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochym Biophys Acta 1996; 1317: 65-70.
59. Hatfield ARW, Terblanche J, Fataar S. Preoperative external biliary drainage in obstructive jaundice: A prospective controlled trial. Lancet 1992; ii: 896-899.
60. Heuman D, Gallay P, Betz-Corradin S. Competition between bactericidal/permeability increasing protein and lipopolysaccharide binding to monocytes. J Infect Dis 1993; 167: 1351-1357.
61. Higaki I, Yamzaki O, Matsuyama M, et al. Serum endothelin-1 and hepatocyte growth factor levels in patients with obstructive jaundice. Hepatogastroenterol 1999; 46: 1599-1602.
62. Higuchi H, Miyoshi H, Bronk SF, Zhang H, Dean N, Gores GJ. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. J Pharmacol Exp Ther 2001; 299: 866-873.
63. Hirazawa K, Hazama S, Oka M. Depressed cytotoxic activity of hepatic nonparenchymal cells in rats with obstructive jaundice. Surgery 1999; 126: 900-907.
64. Hisama M, Yamaguchi Y, Miyanami N, et al. Ischemia-reperfusion injury: The role of Kupffer cells in the production of cytokine-induced neutrophil chemoattractant, a member of interleukin-8 family. Transplant Proc 1995; 27: 1604-1606.
65. Hoffmann R, Grewe M, Estler H-C, Schulze-Specking A, Decker K. Regulation of tumor necrosis factor alpha mRNA synthesis and distribution of tumor necrosis factor alpha mRNA synthesizing cells in rat liver during experimental endotoxaemia. J Hepatol 1994; 20: 122-128.
66. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999; 159: 2647-2658.
67. Hori Y, Ohyanagi H. Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice. Surg Today 1997; 27: 140-144.
68. Houdijk AP, Boermeester MA, Wesdorp RI, Hack CE, Van Leeuwen PA. Tumor necrosis factor unresponsiveness after surgery in bile duct-ligated rats. Am J Physiol 1996; 271: G980-986.
69. Houdijk AP, van Lambalgen AA, Thijs LG, van Leeuven PA. Gut endotoxin restriction improves post-operative haemodynamics in bile duct ligated rat. Shock 1998; 9: 282-288.
70. Houdijk AP, van Leeuwen PA, Boermeester M, Wesdorp R. Reduced splanchnic blood flow following surgery in obstructive jaundice is prevented by external cholestyramine. Gastroenterology 1993; 104 (suppl): A245.
71. Houdijk AP, van Leeuwen PA, Boermeester M, Wesdorp R. Enteral cholestyramine prevents fall in renal blood flow following surgery in obstructive jaundice. Gastroenterology 1993; 104 (suppl): A365.
72. Houdijk AP, Teerlink T, Visser JJ, van Lambalgen AA, van Leeuwen PA. Arginine deficiency in bile duct-ligated rats after surgery: the role of plasma arginase and gut endotoxin restriction. Gastroenterology 1997; 113: 1375-1383.
73. Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappa B. Brain Res 2000; 857: 246-251.
74. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR. Anoxia-reoxygenation induced neutrophil mediated endothelial cell injury: Role of elastase. Am J Physiol 1990; 259: 925-931.
75. Jiang WG, Puntis MCA. Monocyte and blood interleukin-12 levels in patients with obstructive jaundice. HPB Surg 1996; 9: 219-221.
76. Jiang WG, Puntis MCA. Immune dysfunction in patients with obstructive jaundice, mediators and implications for treatments. HPB Surgery 1997; 10: 129-142.
77. Jiang WG, Puntis MCA, Hallett MB. Neutrophil priming by cytokines in patients with obstructive jaundice. HPB Surg 1994; 7: 281-289.
78. Jiang WG, Puntis MC, Horrobin DF, Scott C, Hallet MB. Inhibition of neutrophil respiratory burst and cytokine priming by gamma-linolenic acid. Br J Surg 1996; 83: 659-664.
79. Katz S, Pescovitz OH, Grosfeld JL. Growth failure and decreased levels of insulin-like growth factor-1 in obstructive jaundice are reversed by bile diversion. J Pediatr Surg 1991; 26: 900-903.
80. Katz S, Yang R, Rodefeld MJ, Folkening WJ, Grosfeld JL. Impaired hepatic bacterial clearance is reversed by surgical relief of obstructive jaundice. J Pediatr Surg 1991; 26: 401-406.
81. Kawaguchi K, Koike M. Glomerular alterations associated with obstructive jaundice. Hum Pathol 1987; 18: 1149-1154.
82. Keane RM, Gadacz TR, Munster AM, Birmingham W, Winchurch RA. Impairment of human lymphocyte function by bile salts. Surgery 1984; 95: 439-443.
83. Keller GA, West MA, Cerra FB, Simmons RL. Multiple system organ failure: Modulation of hepatocyte protein synthesis by endotoxin-activated Kupffer cells. Ann Surg 1985; 201: 87-95.
84. Kennedy JA, Clements WDB, Kirk SJ, et al. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg 1999; 86: 628-633.
85. Kennedy JA, Kirk SJ, McCrory DC, Halliday MI, Barclay GR, Rowlands BJ. Modulation of immune function and weight loss by L-arginine in obstructive jaundice in the rat. Br J Surg 1994; 81: 1199-1201.
86. Kigawa G, Nakano H, Kumada K, et al. Improvement of portal flow and hepatic microcirculatory tissue flow with N-acetylcysteine in dogs with obstructive jaundice produced by bile duct ligation. Eur J Surg 2000; 166: 77-84.
87. Kimmings AN, van Deventer SJ, Obertop H, Gouma DJ. Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct ligated rats. J Am Coll Surg 1999; 198: 374-379.
88. Kimmings AN, van Deventer SJH, Obertop H, Rauws EAJ, Gouma DJ. Inflammatory and immunologic effects of obstructive jaundice: Pathogenesis and treatment. J Am Coll Surg 1995; 181: 567-581.
89. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregste K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000; 46: 725-731.
90. Kimmings N, Sewnath ME, Mairuhu WM, et al. The abnormal lipid spectrum in malignant obstuctive jaundice in relation to endotoxin sensitivity and the result of preoperative biliary drainage. Surgery 2001; 129: 282-291.
91. Kimura F, Miyazaki M, Suwa T, et al. Hyperactive cytokine response after partial hepatectomy in patients with biliary obstruction. Eur Surg Res 1998; 30: 259-267.
92. Kimura F, Miyazaki M, Suwa T, et al. Serum interleukin-6 levels in patients with biliary obstruction. Hepatogastroenterology 1999; 46: 1613-1617.
93. Koeppel TA, Lehmann TG, Thies JC, et al. Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation. Transplantation 1996; 61: 1397-1402.
94. Koeppel TA, Thies JC, Lehman T. Improvement of hepatic microhaemodynamics by N-acetylcysteine after warm ischemia. Eur Surg Res 1996; 28: 125-130.
95. Koeppel TA, Trauner M, Baas JC, et al. Extrahepatic biliary obstruction impairs microvascular perfusion and increases leucocyte adhesion in rat liver. Hepatology 1997; 26: 1085-1091.
96. Kren BT, Trembley JH, Krajewski S, Behrens TW, Reed JC, Steer CJ. Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration. Cell Growth Differ 1996; 7: 1633-1642.
97. Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J Hepatol 2000; 32: 3-18.
98. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ. Hepatocytes in the bile duct ligated rat express Bcl-2. Am J Physiol 1997; 272: 1587-1593.
99. Kuzu MA, Kale IT, Cöl C, Tekeli A, Tanik A, Köksoy C. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology 1999; 46: 2159-2164.
100. Lai ECS, Mok FPT, Fan ST, Lo CM, Chu KM, Liu CL. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994; 81: 1195-1198.
101. Lane DR, Josji P, Grogan JB, Nie CH, Scott-Conner CE. Suppression of natural killer cell activity in biliary obstruction. Am Surg 1996; 62: 259-262.
102. Levy R, Schlaeffer F, Keynan A, Nagauker O, Yaari A, Sikuler E. Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 1993; 17: 908-914.
103. Li H, Xiong ST, Zhang SX, Liu SB, Luo Y. Immunological status of patients with obstructive jaundice and immunostimulatory effect of arginine. J Tongji Med Univ 1993; 13: 111-115.
104. Li H, Xiong ST, Zhang SX, Luo Y, Feng ZH. Effect of arginine on immune function in rats with obstructive jaundice. J Tongji Med Univ 1991; 11: 150-154.
105. Li P, Nijhawan D, Budihardjo I, et al. Cytochrom and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
106. Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappa B. Ann Clin Lab Sci 2001; 31: 383-390.
107. Lloyd AR, Biragyn A, Johnston JA, et al. Granulocyte colony stimulating factor and lipopolysaccharide regulate the expression of interleukin-8 receptors on polymorphonuclear leucocytes. J Biol Chem 1995; 270: 28188-28192.
108. Lygidakis NJ, van der Heyde MN, Lubbers MJ. Evaluation of preoperative biliary drainage in the surgical management of pancreatic head carcinoma. Acta Chir Scand 1987; 153: 665-668.
109. Manna SK, Bhattacharya C, Gupta SK. Regulation of interleukin-8 receptor expression in human polymorphonuclear neutrophils. Mol Immunol 1995; 32: 883-893.
110. Marra MN, Wilde CG, Collins MS. The role of bactericidal/permeability increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148: 532-537.
111. McPherson GAD, Benjamin IS, Hodgson HJF. Preoperative percutaneous transhepatic biliary drainage: The results of a controlled trial. Br J Surg 1994; 71: 371-375.
112. Mege JL, Gomez-Cambronero J, Molski TFP, Becker EL, Sha'afi RI. Effect of granulocyte-macrophage colony-stimulating factor on superoxide production in cytoplasts and intact human neutrophils. J Leukoc Biol 1989; 46: 161-168.
113. Megison SM, Dunn CW, Horton JW, Chao H. Effects of relief of biliary obstruction on mononuclear phagocyte system function and cell mediated immunity. Br J Surg 1991; 78: 568-571.
114. Michida T, Kawano S, Masuda E, et al. Role of endothelin 1 in hemorrhagic shock-induced gastric mucosal injury in rats. Gastroenterology 1994; 106: 988-993.
115. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481.
116. Mitsuyoshi H, Nakashima T, Sumida Y, et al. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun 1999; 263: 537-542.
117. Miyoshi H, Gores GJ. Apoptosis and the liver: Relevance for the hepato-biliary-pancreatic surgeon. J Hepatobiliary Pancreat Surg 1998; 5: 409-415.
118. Miyoshi H, Rust C, Guicciardi ME, Gores GJ. NF-kappa B is activated in cholestasis and functions to reduce liver injury. Am J Pathol 2001; 158: 967-975.
119. Muriel P, Gonzalez P. Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998; 120: 421-424.
120. Musso T, Espinoza-Delgado I, Pulkki K, Gusella GL, Longo DL, Varesio L. Transforming growth factor β downregulates interleukin-1 (IL-1) induced IL-6 production by human monocytes. Blood 1990; 76: 2466-2469.
121. Myers CL, Wertheimer SJ, Schembri King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-alpha, IL-1-beta, and LPS in human endothelial cells after down-regulation of PKC. Am J Physiol 1992; 263: 767-772.
122. Neuschwander-Tetri BA, Bellezzo JM, Britton RS, Bacon BR, Fox ES. Thiol regulation of endotoxin-induced tumor necrosis factor release from isolated Kupffer cells. Biochem J 1996; 320: 1005-1010.
123. O'Neil S, Hunt J, Filkins J, Gamelli R. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-alpha and systemic and tissue tumor necrosis factor-alpha levels after endotoxin. Surgery 1997; 122: 281-287.
124. Ogle CK, Ogle JD, Johnson C, Keynton L, Alexander JW. Inhibition of lymphocyte proliferation by fluid-phase C3b as influenced by macrophages. Arch Surg 1987; 122: 234-238.
125. Ohshio G, Furukawa F, Manabe T, Tobe T, Hamashima I. Relationship between secretory IgA, IgA containing (C3 fixing) circulating immune complexes, and complement components (C3-C4) in patients with obstructive jaundice. Scand J Gastroenterol 1986; 21: 151-157.
126. Ohtsuka M, Miyazaki M, Ito H, et al. Two cases of hepatic hilar ductal carcinoma of postoperative liver failure with remarkable polymorphonuclear neutrophils infiltration in the liver tissue at autopsy. Tandou 1993; 7: 71-78.
127. Ohtsuka M, Miyazaki M, Kondo Y, Nakajima N. Neutrophil-mediated sinusoidal endothelial cell injury after extensive hepatectomy in cholestatic rats. Hepatology 1997; 25: 636-641.
128. Ohtsuka M, Miyazaki M, Kubosawa H et al. Role of neutrophils in sinusoidal endothelial cell injury after extensive hepatectomy in cholestatic rats. J Gastroenterol Hepatol 2000; 15: 880-886.
129. Okada K, Marubayashi S, Fukuma K, Yamada K, Dohi K. Effect of the 21-aminosteroid on nuclear factor-kappaB activation of Kupffer cells in endotoxin shock. Surgery 2000; 127: 79-86.
130. Okamura K, Noshima S, Esato K. Cytokine release during hypoxia reoxygenation by Kupffer cells in rats with obstructive jaundice. Surg Today 1999; 29: 730-734.
131. Orban Z, Mitsiades N, Burke Jr TR, Tsokos M, Chrousos GP. Caffeic acid phenethyl ester induces leucocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation 1999; 7: 99-105.
132. Pain JA, Bailey ME. Experimental and clinical study of lactulose in obstructive jaundice. Br J Surg 1986; 73: 775-778.
133. Pain JA, Bailey ME. Prevention of endotoxaemia in obstructive jaundice - Comparative study of bile salts. HPB Surg 1988; 1: 21-27.
134. Pain JA, Cahill CJ, Gilbert JM, Johnson CD, Trapnell JE, Bailey ME. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: A multicentre study of bile salts and lactulose. Br J Surg 1991; 78: 467-469.
135. Pain JA, Collier DS, Ritson A. Reticuloendothelial system phagocytic function in obstructive jaundice and its modification by a muramyl dipeptide analogue. Eur Surg Res 1987; 19: 16-22.
136. Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T. Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 1996; 83: 1345-1349.
137. Patel T, Bronk SF, Gores GJ. Increase of intracellular magnesium promotes glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94: 2183-2192.
138. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996; 10: 587-597.
139. Pitt HA, Gomes AS, Lois JF. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201: 545-553.
140. Polzien F, Ramadori G. Increased intercellular adhesion molecule-1 serum concentration in cholestasis. J Hepatol 1996; 25: 877-886.
141. Plusa S, Webster N, Primrose J. Obstructive jaundice causes reduced expression of polymorphonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro. Gut 1996; 38: 784-787.
142. Puntis MCA, Jiang WG. Imbalance between TNFα and TNF inhibitor in patients with obstructive jaundice. HPB Surg 1993; 6 (Suppl): 87.
143. Puntis MCA, Jiang WG. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. J Gastroenterol Hepatol 1996; 11: 7-13.
144. Reynolds JV, Murchan P, Leonard N, Clarke P, Keane FBV, Tanner WA. Gut barrier failure in experimental obstructive jaundice. J Surg Res 1996; 62: 11-16.
145. Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology 1999; 30: 351-357.
146. Robinson BS, Hii CS, Ferrante A. Activation of phospholipase A2 in human neutrophils by polyunsaturated fatty acids and its role in stimulation of superoxide production. Biochem J 1998; 336: 611-617.
147. Rodrigues CMP, Fan G, Ma X, Brites D, Kren DT, Steer CJ. A novel role for ursodeoxycholic acid in modulating apoptosis in rat liver, isolated rat hepatocytes and human hepatoma cells. Hepatology 1997; 26: 366.
148. Rodriguez-Fragoso L, Gonzalez MP, Muriel P. Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator. Pharmacology 1995; 51: 341-346.
149. Roughneen PT, Didlake R, Kumar SC, Kahan BD, Rowlands BJ. Enhancement of heterotopic cardiac allograft survival by experimental biliary ligation. Transplantation 1987; 43: 437-438.
150. Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands BJ. Impaired specific cell-mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage. J Surg Res 1986; 41: 113-125.
151. Roughneen PT, Kumar SC, Pellis NR, Rowlands BJ. Endotoxemia and cholestasis. Surg Gynecol Obstet 1988; 167: 205-210.
152. Rust C, Sauter GH, Oswald M, et al. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. Eur J Clin Invest 2000; 30: 135-139.
153. Saito JM, Maher JJ. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000; 118: 1157-1168.
154. Sample AK, Czuprynski CJ. Priming and stimulation of bovine neutrophils by human interleukin-1 alpha and tumor necrosis factor alpha. J Leukoc Biol 1991; 49: 107-115.
155. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1993; 57: 316-336.
156. Scott-Conner CE, Grogan JB. Serum and cellular factors in murine obstructive jaundice. Surgery 1994; 115: 77-84.
157. Sedgwick AD, Sin YM, Edwards JCW. Increased inflammatory reactivity in newly formed lining tissue. J Pathol 1983; 141: 483-495.
158. Sheen-Chen SM, Chau P, Harris HW. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J Surg Res 1998; 80: 205-209.
159. Shimizu Y, Miyazaki M, Ito H, et al. Enhanced endothelial cell injury by activated neutrophils in patients with obstructive jaundice. J Hepatol 1997; 27: 803-809.
160. Smith RC, Pooley M, George CRP, Faithful GR. Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomised controlled trial examining renal function. Surgery 1985; 86: 641-647.
161. Spinas G, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxemia. J Clin Invest 1992; 90: 533-536.
162. Stahelin BJ, Marty U, Zimmermann H, Reichen J. The interaction of Bcl-2 and Bax regulates apoptosis in biliary epithelial cells of rats with obstructive jaundice. Virchows Arch 1999; 434: 333-339.
163. Sun Z, Wang X, Lasson Å, et al. Roles of platelet-activating factor, interleukin-1β and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion. J Surg Res 1999; 87: 90-100.
164. Swain MG, Tjandra K, Kanwar S, Kubes P. Neutrophil adhesion impaired in a rat model of cholestasis. Gastroenterology 1995; 109: 923-932.
165. Tahara H, Zeh HJ, Storkus J, et al. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994; 54: 182-189.
166. Takaoka M, Kubota Y, Tsuji K, et al. Human neutrophil functions in obstructive jaundice. Hepatogastroenterology 2001; 48: 71-75.
167. Takiguchi S, Koga A. Effects of bile acids and endotoxin on the function and morphology of cultured hamster Kupffer cells. Virchow Arch (Cell Biol) 1988; 54: 303-311.
168. Thompson RL, Hoper M, Diamond T, Rowlands BJ. Development and reversibility of lymphocyte dysfunction in experimental obstructive jaundice. Br J Surg 1990; 77: 1229-1232.
169. Trede M. The complication of pancreatectomy. Ann Surg 1988; 207: 39-47.
170. van Leeuwen PA, Boermeester MA, Houdijk AP. Pretreatment with enteral cholestyramine prevents suppression of cellular immune system following partial hepatectomy. Ann Surg 1995; 221: 282-290.
171. Vane DW, Redlich P, Weber T, Leapman S, Siddiqui AR, Grosfeld JL. Impaired immune functions in obstructive jaundice. J Surg Res 1998; 45: 287-293.
172. Villa P, Kaufmann SH, Earnshaw WC. Caspase and caspase inhibitors. Trends Biochem Sci 1997; 22: 388-393.
173. Waage A, Sorensen M, Stordal B. Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production. Lancet 1990; 335: 543.
174. Wang QH. Effects of obstructive jaundice on immunocompetence in jaundiced patients. Zhonghua Wai Ke Za Zhi 1993; 31: 148-152.
175. Wang XD, Pärsson H, Andersson R. Bacterial translocation, intestinal ultrastructure and cell membrane permeability early after major liver resection in the rat. Br J Surg 1994; 81: 579-584.
176. Wells CL, Jechorek RP, Erlandsen SL. Inhibitory effect of bile on bacterial invasion of enterocytes: possible mechanism for increased translocation is associated with obstructive jaundice. Crit Care Med 1995; 23: 301-307.
177. Welsh FKS, Ramsden CW, MacLennan K, et al. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg 1998; 227: 205-212.
178. White JE, Lin HY, Davis PJ, Tsan MF. Differential induction of tumour necrosis factor alpha and manganese superoxide dismutase by endotoxin in human monocytes: Role of protein tyrosine kinase, mitogen-activated protein kinase, and nuclear factor kappa B. J Cell Physiol 2000; 182: 381-389.
179. Williams RC, Showalter R, Kern F. In vivo effect of bile salts and cholestyramine on intestinal anaerobic bacteria. Gastroenterology 1975; 69: 483-491.
180. Withrington PG, de Nucci G, Vane JR. Endothelin-1 causes vasoconstriction and vasodilatation in the blood perfused liver of the dog. J Cardiovasc Pharmacol 1989; 13: 209-210.
181. Wood JG, Yan ZY, Davis JM, Cheung LY. Phosphoramidon attenuates big endothelin-1-induced vasoconstriction in canine stomach. Am J Physiol 1994; 266: G311-317.
182. Zimmermann H, Reichen J, Zimmermann A, Sägesser H, Tenisch B, Höflin F. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Gastroenterology 1992; 103: 579-589.
183. Yanagitani K, Yoshitsugu K, Tsuji K, et al. Influence of biliary obstruction on neutrophil chemotaxis. Gastroenterology 1998; 33: 536-540.
184. Yong KL, Rowles PMK, Patterson G, Linch DC. Granulocyte-macrophage colony-stimulating factor induces neutrophil adhesion to pulmonary vascular endothelium in vivo: Role of β2 integrins. Blood 1992; 80: 1565-1575.